Non-Live Vaccines/Teplizumab Interactions
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Medical warning:
Serious. These medicines may interact and cause very harmful effects. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
Teplizumab may decrease your immune system's response to vaccination.
What might happen:
Vaccinations may not work as well if you receive them within 2 weeks before, during, or within 6 weeks after stopping teplizumab therapy.
What you should do about this interaction:
Make sure your healthcare professionals (e.g. doctor or pharmacist) know that you are taking or if you have taken teplizumab within the previous 6 weeks. Your doctor may want to perform a blood test a few weeks after your vaccination to determine if the vaccine worked.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
- 1.Tzield (teplizumab-mzwv) US prescribing information. Provention Bio, Inc. November, 2022.
- 2.Kroger A Bahta L Long S Sanchez P. General Best Practice Guideline for Immunization. Best Practices Guidance of the Advisory Committee on Immunzation Practices (ACIP). MMWR. Available at: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/downloads/general- recs.pdf February 10, 2023;1-197.
- 3.Centers for Disease Control and Prevention (CDC). Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States. Accessed at: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vac cines-us.html Last updated: September 15, 2023.
- 4.Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, etal. American College of Rheumatology COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic and Musucloskeletal Diseases - Version 5. Arthritis and Rheumatology. Available at: https://www.rheumatology.org/Portals/0/Files/COVID-19-Vaccine-Clinical-Gui dance-Rheumatic-Diseases-Summary.pdf February 2, 2022.
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.